In obesity, T2DM and NAFLD, hyperinsulinemia and dysregulated insulin signaling occurs when insulin and IGF-1 bind to their respective receptors and activate PI3K/Akt signaling, a key oncogenic pathway for metabolism, cell growth and cell survival (66, 88). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.